Dabur announces fresh investment of Rs 550 crore
The company said in a statement the new plant, which would be involved in the production of making foods, ayurvedic medicines and health supplements would provide direct and indirect employment to 1,250 people in the first phase and over 3,000 peo...
The company said in a statement the new plant, which would be involved in the production of making foods, ayurvedic medicines and health supplements would provide direct and indirect employment to 1,250 people in the first phase and over 3,000 people subsequently.
"We have a clear growth strategy; this facility will provide us space to rapidly expand production capacity for ayurvedic products and medicines, as well as innovative foods,” Dabur chief executive officer Mohit Malhotra said.
Since the Covid outbreak, demand for ayurvedic products has seen rapid growth. Products like Chyawanprash, honey, and health juices have been witnessing record growth across channels including e-commerce.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.